Terms and Data
Intraday Chart Close
Call Level76 Spot to Call Level9.5 / 11.11 %
Strike71.8 Difference between
Call & Strike Price4.20
Effective Gearing(X)*N/A Delta*New
Entitlement Ratio100 Approximate Change for 1 Tick
Price Change of CBBC (Sensitivity)*0.1HKD
CBBCTypeR Outstanding Quantity
(M) / %New/ New
Maturity
(Y-M-D)2026-10-30
Premium (%)New
Listing 2026-03-11
Today 2026-03-10
Last Trading 2026-10-29
Maturity 2026-10-30
Last Trade Date (YYYY-MM-DD)2026-10-29 Break-Even (HKD)71.8
Board Lot (Shares)5,000  
Listing 2026-03-11
Today 2026-03-10
Last Trading 2026-10-29
Maturity 2026-10-30
*Effective Gearing, Delta and Price per Tick are based on the pricing model of DBPower. Any inaccuracies, computational mistakes or omissions are not within J.P. Morgan’s control.
Related Document
Listing Document Download Additional Document- Announcement-
Underlying
85.00
Change (%)
+3.250 (+4.0%)
  • High 85.95
  • Low 83.65
  • Turnover 296.3 (M)
CBBC Money Flow of Underlying More
Last Day
-0.21(M)
-0.01(M)
5 Days
0.26(M)
-0.06(M)
  • Money In-Flow
  • Money Out-Flow
Last Updated Time : 2026-03-10 10:25   |   (Delayed*) - Minimum 15 mins delayed
  • 2026-02-09 【焦點股份】信達生物再與禮來製藥達成全球戰略合作 推進腫瘤及免疫領域創新藥物的全球研發 信藥購 17515
  • 2025-12-09 【焦點藍籌】信達生物上日首日染藍後下挫近7% 信藥購 17515/牛65595
  • 2025-11-24 【焦點股份】信達生物製藥獲納入香港恒生指數 將於12月8日生效 信藥購19131